Xencor
XNCR
$24.11
Share price
2.03%
Change (1 day)
-12.07%
Change (1 year)
Categories
Xencor (XNCR) - Cash on Hand
Cash on Hand as of December 2023 : $0.59 B
According to Xencor's latest financial reports the company has $0.59 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Xencor - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.59 B | -4.71% |
| 2022-12-31 | $0.62 B | 86.49% |
| 2021-12-31 | $0.33 B | -44.59% |
| 2020-12-31 | $0.60 B | 13.82% |
| 2019-12-31 | $0.52 B | 79.98% |
| 2018-12-31 | $0.29 B | 31.33% |
| 2017-12-31 | $0.22 B | 72.23% |
| 2016-12-31 | $0.13 B | 34.95% |
| 2015-12-31 | $96.43 M | 76.45% |
| 2014-12-31 | $54.64 M | -29.91% |
| 2013-12-31 | $77.97 M | 3272.62% |
| 2012-12-31 | $2.31 M | -84.1% |
| 2011-12-31 | $14.53 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 3,761.55% | 🇺🇸 USA |
 AbbVie ABBV | $12.81 B | 2,058.58% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 1,743.28% | 🇺🇸 USA |
 Merck MRK | $7.09 B | 1,094.66% | 🇺🇸 USA |
 Seagen
SGEN | $1.23 B | 108.34% | 🇺🇸 USA |
 MacroGenics MGNX | $0.22 B | -61.29% | 🇺🇸 USA |